De Wit S et al. |
Acquired resistance to clarithromycin as combined therapy in Mycobacterium avium intracellulare infection. |
1993 |
Lancet |
pmid:8093299
|
Monteforte JS and Wood CA |
Pneumonia caused by Nocardia nova and Aspergillus fumigatus after cardiac transplantation. |
1993 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:8500477
|
Hakkarinen WD |
Clarithromycin vs penicillin. |
1993 |
J Fam Pract |
pmid:8482929
|
Luger SW |
Clarithromycin vs penicillin. |
1993 |
J Fam Pract |
pmid:8482930
|
Pialoux G et al. |
Combination antibiotic treatment with clarithromycin for human immunodeficiency virus-associated Rhodococcus equi infection. |
1993 |
Clin. Infect. Dis. |
pmid:8218702
|
Fraschini F et al. |
Clarithromycin clinical pharmacokinetics. |
1993 |
Clin Pharmacokinet |
pmid:8222460
|
Neu HC and Chick TW |
Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections. |
1993 |
Chest |
pmid:8222794
|
Sedlmayr T et al. |
[Clarithromycin, a new macrolide antibiotic. Effectiveness in puerperal infections and pharmacokinetics in breast milk]. |
1993 |
Geburtshilfe Frauenheilkd |
pmid:8370491
|
Kodama R et al. |
[Eradication therapy of Helicobacter pylori in gastroduodenal ulcer and its long-term course]. |
1993 |
Nippon Rinsho |
pmid:8283646
|
Gevaudan MJ et al. |
In-vitro evaluation of clarithromycin, temafloxacin, and ethambutol in combination against Mycobacterium avium complex. |
1993 |
J. Antimicrob. Chemother. |
pmid:8392998
|
Wallace RJ et al. |
Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. |
1993 |
Ann. Intern. Med. |
pmid:8357113
|
Wettengel R et al. |
Clarithromycin versus cefaclor for the treatment of mild-to-moderate acute bacterial bronchitis. |
1993 |
J. Antimicrob. Chemother. |
pmid:8360133
|
Nakashio S et al. |
[Antimicrobial activity of clarithromycin and its effect on bacterial adherence to medical material]. |
1993 |
Jpn J Antibiot |
pmid:8360978
|
Mor N and Heifets L |
MICs and MBCs of clarithromycin against Mycobacterium avium within human macrophages. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8431006
|
Tomioka H et al. |
In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8431020
|
Chu SY et al. |
Effect of moderate or severe hepatic impairment on clarithromycin pharmacokinetics. |
1993 |
J Clin Pharmacol |
pmid:8331208
|
Graham DY et al. |
Clarithromycin for the eradication of Helicobacter pylori. |
1993 |
J. Clin. Gastroenterol. |
pmid:8331260
|
Guay DR et al. |
Overview of the tolerability profile of clarithromycin in preclinical and clinical trials. |
1993 |
Drug Saf |
pmid:8504017
|
Mazzei T et al. |
Chemistry and mode of action of macrolides. |
1993 |
J. Antimicrob. Chemother. |
pmid:7683018
|
Lazard T et al. |
Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice. |
1993 |
Antimicrob. Agents Chemother. |
pmid:7684213
|
Emori M et al. |
Therapeutic efficacy of the benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbits. |
1993 |
Antimicrob. Agents Chemother. |
pmid:7684214
|
Ruf B et al. |
Effectiveness of the macrolide clarithromycin in the treatment of Mycobacterium avium complex infection in HIV-infected patients. |
1992 Sep-Oct |
Infection |
pmid:1428183
|
Friend DR |
Polyacrylate resin microcapsules for taste masking of antibiotics. |
1992 Oct-Dec |
J Microencapsul |
pmid:1403495
|
de Campora E et al. |
Comparative efficacy and safety of roxithromycin and clarithromycin in upper respiratory tract infections. |
1992 May-Jun |
Diagn. Microbiol. Infect. Dis. |
pmid:1535578
|
Nilsen OG et al. |
Macrolide pharmacokinetics and dose scheduling of roxithromycin. |
1992 May-Jun |
Diagn. Microbiol. Infect. Dis. |
pmid:1535579
|
Hoover WW et al. |
Clarithromycin in vitro activity enhanced by its major metabolite, 14-hydroxyclarithromycin. |
1992 Mar-Apr |
Diagn. Microbiol. Infect. Dis. |
pmid:1533827
|
Chapelsky MC et al. |
Renal tubular enzyme effects of clarithromycin in comparison with gentamicin and placebo in volunteers. |
1992 Jul-Aug |
Drug Saf |
pmid:1355971
|
Logan RP et al. |
Clarithromycin and omeprazole for Helicobacter pylori. |
1992 |
Lancet |
pmid:1353155
|
Hammerschlag MR et al. |
In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324650
|
Paulsen P et al. |
Influence of azithromycin and other macrolides on the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes of healthy donors and a patient with Chédiak-Higashi syndrome. |
1992 |
Chemotherapy |
pmid:1324831
|
Hardy DJ et al. |
Clarithromycin, a unique macrolide. A pharmacokinetic, microbiological, and clinical overview. |
1992 |
Diagn. Microbiol. Infect. Dis. |
pmid:1530914
|
Chu S et al. |
Drug-food interaction potential of clarithromycin, a new macrolide antimicrobial. |
1992 |
J Clin Pharmacol |
pmid:1531484
|
Heifets LB et al. |
Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium. |
1992 |
Am. Rev. Respir. Dis. |
pmid:1532486
|
Guay DR and Craft JC |
Comparative safety and efficacy of clarithromycin and ampicillin in the treatment of out-patients with acute bacterial exacerbation of chronic bronchitis. |
1992 |
J. Intern. Med. |
pmid:1532615
|
Ruf B et al. |
Failure of clarithromycin in preventing toxoplasmic encephalitis in AIDS patients. |
1992 |
J. Acquir. Immune Defic. Syndr. |
pmid:1532831
|
Cynamon MH and Klemens SP |
Activity of azithromycin against Mycobacterium avium infection in beige mice. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1329622
|
Ruf B et al. |
Acquired resistance of MAI to clarithromycin. |
1992 |
Am. Rev. Respir. Dis. |
pmid:1533999
|
Chonmaitree T et al. |
Effect of viral respiratory tract infection on outcome of acute otitis media. |
1992 |
J. Pediatr. |
pmid:1534364
|
Knothe H |
[Short-term therapy of acute respiratory and ORL infections with Clarithromycin]. |
1992 |
Z Gesamte Inn Med |
pmid:9022402
|
Bale MJ et al. |
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin. |
1992 |
J. Clin. Microbiol. |
pmid:1310329
|
Neu HC |
New macrolide antibiotics: azithromycin and clarithromycin. |
1992 |
Ann. Intern. Med. |
pmid:1310839
|
Brown BA et al. |
Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1317144
|
Bahal N and Nahata MC |
The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin. |
1992 |
Ann Pharmacother |
pmid:1318761
|
Berk SL |
New macrolide antibiotics. |
1992 |
Ann. Intern. Med. |
pmid:1386966
|
Chu SY et al. |
Absolute bioavailability of clarithromycin after oral administration in humans. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1387301
|
Yajko DM et al. |
Comparison of the intracellular activities of clarithromycin and erythromycin against Mycobacterium avium complex strains in J774 cells and in alveolar macrophages from human immunodeficiency virus type 1-infected individuals. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1387302
|
de Lalla F et al. |
Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1387303
|
Cohen Y et al. |
Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophages. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1332586
|
Sifrim D et al. |
Comparison of the effects of midecamycin acetate and clarithromycin on gastrointestinal motility in man. |
1992 |
Drugs Exp Clin Res |
pmid:1292916
|
Dautzenberg B |
[Treatment of atypical mycobacterium infections: current state and therapeutic perspectives]. |
1992 |
Rev Pneumol Clin |
pmid:1296257
|
Peters DH and Clissold SP |
Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential. |
1992 |
Drugs |
pmid:1379907
|
Calzolari E et al. |
The efficacy of clarythromycin (A-56268, TE-031) in the treatment of genital chlamydial infection. |
1992 |
Drugs Exp Clin Res |
pmid:1306155
|
Klemens SP et al. |
Activity of clarithromycin against Mycobacterium avium complex infection in beige mice. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1336945
|
Ji B et al. |
Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice. |
1992 |
Int. J. Lepr. Other Mycobact. Dis. |
pmid:1338596
|
Yajko DM |
In vitro activity of antimicrobial agents against the Mycobacterium avium complex inside macrophages from HIV1-infected individuals: the link to clinical response to treatment? |
1992 |
Res. Microbiol. |
pmid:1455069
|
Omura S et al. |
[Research and development of clarithromycin]. |
1992 |
Yakugaku Zasshi |
pmid:1469609
|
Chu SY et al. |
Clarithromycin pharmacokinetics in healthy young and elderly volunteers. |
1992 |
J Clin Pharmacol |
pmid:1474166
|
Gelber RH et al. |
Clarithromycin at very low levels and on intermittent administration inhibits the growth of M. leprae in mice. |
1992 |
Int. J. Lepr. Other Mycobact. Dis. |
pmid:1474290
|
Heifets LB et al. |
Bacteriostatic and bactericidal activities of gentamicin alone and in combination with clarithromycin against Mycobacterium avium. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1416852
|
Brown BA et al. |
Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1416891
|
Biehle J and Cavalieri SJ |
In vitro susceptibility of Mycobacterium kansasii to clarithromycin. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1416897
|
Chu SY et al. |
Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489187
|
Araujo FG et al. |
Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489188
|
Gan VN et al. |
Pharmacokinetics of a clarithromycin suspension in infants and children. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489191
|
Sturgill MG and Rapp RP |
Clarithromycin: review of a new macrolide antibiotic with improved microbiologic spectrum and favorable pharmacokinetic and adverse effect profiles. |
1992 |
Ann Pharmacother |
pmid:1421677
|
Denny FW |
Current management of streptococcal pharyngitis. |
1992 |
J Fam Pract |
pmid:1453145
|
Schrock CG |
Clarithromycin vs penicillin in the treatment of streptococcal pharyngitis. |
1992 |
J Fam Pract |
pmid:1453146
|
Chaisson R |
Clarithromycin is effective against M. avium complex in AIDS. |
1992 |
Am Fam Physician |
pmid:1456199
|
Ji B et al. |
Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482155
|
Rastogi N and Goh KS |
Effect of pH on radiometric MICs of clarithromycin against 18 species of mycobacteria. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482156
|
Rastogi N et al. |
Activity of clarithromycin compared with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutol. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482157
|
Derouin F et al. |
Synergistic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482160
|
Takeda H et al. |
[A study to clarify the mechanism of the usefulness of the macrolides--the influence of clarithromycin to biofilm with P. aeruginosa]. |
1992 |
Kansenshogaku Zasshi |
pmid:1363435
|
Rehg JE |
Anti-cryptosporidial activity of macrolides in immunosuppressed rats. |
1991 Nov-Dec |
J. Protozool. |
pmid:1667930
|
Hughes WT |
Macrolide-antifol synergism in anti-Pneumocystis carinii therapeutics. |
1991 Nov-Dec |
J. Protozool. |
pmid:1818149
|
De Punzio C et al. |
Isolation of Chlamydia trachomatis during IVF-ET. |
1991 Jul-Aug |
Acta Eur. Fertil. |
pmid:1844324
|
Cogo R et al. |
[Dynamics of sIgA concentration in bronchial secretions in patients with COBP treated with clarithromycin]. |
1991 Jan-Dec |
G Ital Chemioter |
pmid:1365564
|
Anderson G |
Clarithromycin in the treatment of community-acquired lower respiratory tract infections. |
1991 |
J. Hosp. Infect. |
pmid:1684979
|
Davey PG |
The pharmacokinetics of clarithromycin and its 14-OH metabolite. |
1991 |
J. Hosp. Infect. |
pmid:1684980
|
King A and Phillips I |
A comparison of the in-vitro activity of clarithromycin, a new macrolide antibiotic, with erythromycin and other oral agents. |
1991 |
J. Hosp. Infect. |
pmid:1684981
|
Wood MJ |
The tolerance and toxicity of clarithromycin. |
1991 |
J. Hosp. Infect. |
pmid:1684982
|
|
Clarithro- and azithromycin--better erythromycins? |
1991 |
Drug Ther Bull |
pmid:1665125
|
Rastogi N et al. |
Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophages. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1667250
|
Gu JW et al. |
Bactericidal activity of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae and streptococcal pathogens. |
1991 |
J Clin Pharmacol |
pmid:1837032
|
Hughes WT and Killmar JT |
Synergistic anti-Pneumocystis carinii effects of erythromycin and sulfisoxazole. |
1991 |
J. Acquir. Immune Defic. Syndr. |
pmid:2016690
|
Rastogi N and Labrousse V |
Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1828135
|
Ji B et al. |
Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1828136
|
Lu MY et al. |
A polymer carrier system for taste masking of macrolide antibiotics. |
1991 |
Pharm. Res. |
pmid:1829521
|
Perronne C et al. |
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1656860
|
Morgan DK et al. |
A reversed-phase high-performance liquid chromatographic method for the determination and identification of clarithromycin as the drug substance and in various dosage forms. |
1991 |
J Pharm Biomed Anal |
pmid:1831386
|
Dautzenberg B et al. |
Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. |
1991 |
Am. Rev. Respir. Dis. |
pmid:1832527
|
Rotsch TD et al. |
Determination of clarithromycin as a contaminant on surfaces by high-performance liquid chromatography using electrochemical detection. |
1991 |
Pharm. Res. |
pmid:1833731
|
Jorgensen JH et al. |
Activity of clarithromycin and its principal human metabolite against Haemophilus influenzae. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1834012
|
Truffot-Pernot C et al. |
Effect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complex. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1834015
|
Hamedani P et al. |
The safety and efficacy of clarithromycin in patients with Legionella pneumonia. |
1991 |
Chest |
pmid:1835689
|
Fernandez-Martin J et al. |
Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1836943
|
Gelber RH et al. |
Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1648889
|
Straneo G and Scarpazza G |
Efficacy and safety of clarithromycin versus josamycin in the treatment of hospitalized patients with bacterial pneumonia. |
1990 Mar-Apr |
J. Int. Med. Res. |
pmid:2140330
|
Fraschini F |
Clinical efficacy and tolerance of two new macrolides, clarithromycin and josamycin, in the treatment of patients with acute exacerbations of chronic bronchitis. |
1990 Mar-Apr |
J. Int. Med. Res. |
pmid:2140331
|
Ferrero JL et al. |
Metabolism and disposition of clarithromycin in man. |
1990 Jul-Aug |
Drug Metab. Dispos. |
pmid:1976065
|